|
171 |
Placebo Effect in Clinical Trials in Autism: Experience from a Pregnenolone Treatment Study
Enthalten in Journal of autism and developmental disorders 18.7.2025: 1-7
|
|
|
|
172 |
A Randomized Placebo-Controlled Trial of the Efficacy and Tolerability of Etofenamate 70 mg Medicated Plaster for the Treatment of Pain in Acute Sprains, Strains or Bruises of the Soft Tissues Following Blunt Trauma
Enthalten in Pain and therapy 17.7.2025: 1-12
|
|
|
|
173 |
Letter to the editor: Effect of BCG vaccination on immune-regulatory markers and glycemic control in children with new-onset type 1 diabetes mellitus (T1DM): A randomised double-blinded placebo-controlled pilot trial
Enthalten in International journal of diabetes in developing countries 16.7.2025: 1-2
|
|
|
|
174 |
Is Lumateperone Effective in Bipolar Depression? A Systematic Literature Review and Meta-Analysis on Placebo-Controlled Trials
Enthalten in Pharmacopsychiatry 14.07.2025
|
|
|
|
175 |
Impact of SGLT2i on bone health in patients with lupus nephritis: randomized double blinded placebo-controlled clinical trial
Enthalten in Journal of nephrology 13.7.2025: 1-11
|
|
|
|
176 |
Altersbedingte Makuladegeneration – Teil 2: therapeutische Optionen bei der AMD
Enthalten in Geriatrie up2date Bd. 07, 2025, Nr. 04: 289-303
|
|
|
|
177 |
Gehirnreaktion auf Gaenslen-Handgriff spricht für guten TNF-Blocker-Effekt
Enthalten in Kompass Autoimmun Bd. 7, 2025, Nr. 4: 198-199. 2 S.
|
|
|
|
178 |
Morbus Crohn: Filgotinib bleibt eine Option zum Off-Label-Einsatz
Enthalten in Kompass Autoimmun Bd. 7, 2025, Nr. 4: 194-195. 2 S.
|
|
|
|
179 |
Subkutanes Efgartigimod: Ein neuer Weg in der Behandlung der CIDP
Enthalten in Kompass Autoimmun Bd. 7, 2025, Nr. 4: 188-190. 3 S.
|
|
|
|
180 |
Plaque-Psoriasis: Langzeitdaten bestätigen positives Sicherheitsprofil von Deucravacitinib
Enthalten in Kompass Autoimmun Bd. 7, 2025, Nr. 2: 68-71. 4 S.
|
|
Administration
